319 related articles for article (PubMed ID: 27930690)
1. Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon.
Oren DA; Wei Y; Skrabanek L; Chow BK; Mommsen T; Mojsov S
PLoS One; 2016; 11(12):e0167718. PubMed ID: 27930690
[TBL] [Abstract][Full Text] [Related]
2. Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for
Wang H; Hu W; Liu D; Wüthrich K
FEBS J; 2021 Jul; 288(13):4053-4063. PubMed ID: 33369025
[TBL] [Abstract][Full Text] [Related]
3. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
[TBL] [Abstract][Full Text] [Related]
4. Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).
Yang D; de Graaf C; Yang L; Song G; Dai A; Cai X; Feng Y; Reedtz-Runge S; Hanson MA; Yang H; Jiang H; Stevens RC; Wang MW
J Biol Chem; 2016 Jun; 291(25):12991-3004. PubMed ID: 27059958
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.
Graaf Cd; Donnelly D; Wootten D; Lau J; Sexton PM; Miller LJ; Ahn JM; Liao J; Fletcher MM; Yang D; Brown AJ; Zhou C; Deng J; Wang MW
Pharmacol Rev; 2016 Oct; 68(4):954-1013. PubMed ID: 27630114
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
Roed SN; Nøhr AC; Wismann P; Iversen H; Bräuner-Osborne H; Knudsen SM; Waldhoer M
J Biol Chem; 2015 Jan; 290(2):1233-43. PubMed ID: 25451942
[TBL] [Abstract][Full Text] [Related]
7. Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway.
Thompson A; Kanamarlapudi V
Biochem Pharmacol; 2015 Jan; 93(1):72-84. PubMed ID: 25449603
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors.
Darbalaei S; Yuliantie E; Dai A; Chang R; Zhao P; Yang D; Wang MW; Sexton PM; Wootten D
Biochem Pharmacol; 2020 Oct; 180():114150. PubMed ID: 32682761
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of the dual agonism at GLP-1R and GCGR.
Li Y; Zhou Q; Dai A; Zhao F; Chang R; Ying T; Wu B; Yang D; Wang MW; Cong Z
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2303696120. PubMed ID: 37549266
[TBL] [Abstract][Full Text] [Related]
10. 7TM Domain Structure of Adhesion GPCRs.
de Graaf C; Nijmeijer S; Wolf S; Ernst OP
Handb Exp Pharmacol; 2016; 234():43-66. PubMed ID: 27832483
[TBL] [Abstract][Full Text] [Related]
11. Implications of ligand-receptor binding kinetics on GLP-1R signalling.
Zhao P; Truong TT; Merlin J; Sexton PM; Wootten D
Biochem Pharmacol; 2022 May; 199():114985. PubMed ID: 35300966
[TBL] [Abstract][Full Text] [Related]
12. A novel humanized GLP-1 receptor model enables both affinity purification and Cre-LoxP deletion of the receptor.
Jun LS; Showalter AD; Ali N; Dai F; Ma W; Coskun T; Ficorilli JV; Wheeler MB; Michael MD; Sloop KW
PLoS One; 2014; 9(4):e93746. PubMed ID: 24695667
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation.
Thompson A; Stephens JW; Bain SC; Kanamarlapudi V
PLoS One; 2016; 11(4):e0154229. PubMed ID: 27100083
[TBL] [Abstract][Full Text] [Related]
14. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
Runge S; Schimmer S; Oschmann J; Schiødt CB; Knudsen SM; Jeppesen CB; Madsen K; Lau J; Thøgersen H; Rudolph R
Biochemistry; 2007 May; 46(19):5830-40. PubMed ID: 17444618
[TBL] [Abstract][Full Text] [Related]
15. Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor.
Underwood CR; Knudsen LB; Garibay PW; Peters GH; Reedtz-Runge S
Peptides; 2013 Nov; 49():100-8. PubMed ID: 24045233
[TBL] [Abstract][Full Text] [Related]
16. Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide.
Chang R; Zhang X; Qiao A; Dai A; Belousoff MJ; Tan Q; Shao L; Zhong L; Lin G; Liang YL; Ma L; Han S; Yang D; Danev R; Wang MW; Wootten D; Wu B; Sexton PM
J Biol Chem; 2020 Jul; 295(28):9313-9325. PubMed ID: 32371397
[TBL] [Abstract][Full Text] [Related]
17. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
[TBL] [Abstract][Full Text] [Related]
18. Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors.
Vishnoi S; Bhattacharya S; Walsh EM; Okoh GI; Thompson D
J Chem Inf Model; 2023 Aug; 63(15):4934-4947. PubMed ID: 37523325
[TBL] [Abstract][Full Text] [Related]
19. The Xenopus proglucagon gene encodes novel GLP-1-like peptides with insulinotropic properties.
Irwin DM; Satkunarajah M; Wen Y; Brubaker PL; Pederson RA; Wheeler MB
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):7915-20. PubMed ID: 9223287
[TBL] [Abstract][Full Text] [Related]
20. Ligand-Receptor Interactions and Machine Learning in GCGR and GLP-1R Drug Discovery.
Mizera M; Latek D
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
